SAN FRANCISCO (MarketWatch) -- Conceptus Inc. on Monday evening said that it has received clearance from the Food and Drug Administration to extend the effectiveness data on the product labeling of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback